276°
Posted 20 hours ago

eSynic Digital Pocket Scale Weight Scale Mini Digital Pocket Scale 0.01-500g Electronic Weighing Scales LED Display for Kitchen Jewellery Drug Weighting and Home Use with Two Transparent Trays

£9.9£99Clearance
ZTS2023's avatar
Shared by
ZTS2023
Joined in 2023
82
63

About this deal

Salahudeen MS, Duffull SB, Nishtala PS. (2015) Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. doi: 10.1186/s12877-015-0029-9. Increasing availability of highly potent cannabis products with increased risk for psychosis and addiction ( 11, 13, 16, 17). The primary electronic literature search identified a total of 1250 articles from 3 different databases such as Ovid MEDLINE, EMBASE, and PsycINFO. EndNote was used to eliminate duplicates and we considered 932 articles for screening. Out of 932 screened articles based on title and abstract, only 21 were eligible for full-text analysis. From the eligible 21 studies, 14 were excluded on full text analysis according to the set inclusion and exclusion criteria. Hence, in total, 7 studies were included in this review that considered expert opinion/s in the development of the anticholinergic rating scales [ 9, 19, 22- 26]. Figure 1 depicts a flow-diagram of the identification, screening, eligibility and exclusion process.

The overall prevalence of drug use reported in the UK has remained relatively stable throughout the last decade. However, the most recent surveys covering England and Wales, and Scotland reported the highest prevalence of drug use in the past 10 years. Kumpula EK, Bell JS, Soini H, Pitkala KH. Anticholinergic drug use and mortality among residents of long-term care facilities: a prospective cohort study. J Clin Pharmacol. 2011;51(2):256–63.Illicit drugs such as methamphetamine, heroin, and cocaine, and also alcohol were judged particularly harmful.

Anticholinergic Cognitive Burden Scale (ACB) developed by Boustani et al. [ 24] is based on a systematic literature review of medicines with known anticholinergic activity. The ACB scale included medicines that were likely to have a negative impact on cognition [ 27, 28]. A multi-disciplinary panel assessed individual drugs to have none, possible, or definite anticholinergic properties with a score ranging from 0 to 3. ACB scale reported 88 medicines with known anticholinergic activity. Studies that employed the ACB scale have shown that higher anticholinergic burden predicts cognitive impairment in older people. In addition, the study conducted by Pasina L et al. showed that anticholinergic burden quantified by the ACB scale predicted impairment in physical functioning [ 27]. Psychotherapy and Psychosomatics, Landschaftsverband Westfalen-Lippe-Hospital Marsberg, Marsberg, Germany for Interdisciplinary Addiction Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany of Psychiatry and Psychotherapy University Hospital, Ludwig-Maximilians-Universität München, Munich, GermanySixteen studies satisfied the inclusion criteria from an initial 496 studies. Fifteen studies identified a significant negative association of anticholinergic burden with mobility measures. One study did not find an association between anticholinergic intervention and mobility measures. Five studies included in the meta-analyses showed that anticholinergic burden significantly decreased walking speed (0.079 m/s ± 0.035 MD ± SE,95% CI: 0.010 to 0.149, p = 0.026), whilst a meta-analysis of four studies showed that anticholinergic burden significantly decreased physical function as measured by three variations of the Instrumental Activities of Daily Living (IADL) instrument 0.27 ± 0.12 (SMD ± SE,95% CI: 0.03 to 0.52), p = 0.027. The results of both meta-analyses had an I 2 statistic of 99% for study heterogeneity. Egger’s test did not reveal publication bias. Conclusion Nitrous oxide: In the last year 1.3% of adults aged 16 to 59 years and 3.9% of adults aged 16 to 24 years had used nitrous oxide, this is equivalent to around 444,000 and 230,000 individuals, respectively; around half as many as reported use in the year ending March 2020. Prescribed drugs including opioids (in contrast to the USA, Canada and Australia) and non-opioid analgesics including gabapentinoids were judged less harmful. Ecstasy: Prevalence of last year ecstasy use was at its lowest level since data were first collected; 0.7% of adults aged 16 to 59 years and 1.1% of adults aged 16 to 24 years had reporting taking this drug in the last year; a 47% decrease for those aged 16 to 59 years and a 72% decrease for those aged 16 to 24 years compared with the year ending March 2020. Fox C, Livingston G, Maidment ID, Coulton S, Smithard DG, Boustani M, et al. The impact of anticholinergic burden in Alzheimer's dementia-the LASER-AD study. Age Ageing. 2011;40(6):730–5.

The Creative Commons Public Domain Dedication waiver ( https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. The most recent (2021) survey on Smoking, Drinking and Drug Use among Young People in England (SDD) showed that the proportion of those aged 11 to 15 years in England who had taken any drug (excluding new psychoactive substances) in the last year was 10.4%. This was lower than previously estimated in 2018 (14.5%). Any Class A drug use The drug-related mortality rate per million population in Great Britain using the EMCDDA definition was the highest on record, at 76 per million. The mortality rate in Scotland was 229 per million in 2017, the highest rate reported in Europe in that year.

Figures

ADS=Anticholinergic Drug Scale; ABC=Anticholinergic Burden Classification; CrAS=Clinician-rated Anticholinergic Score; ARS=Anticholinergic Risk Scale; ACB=Anticholinergic Cognitive Burden Scale; AAS=Anticholinergic Activity Scale; ACL=Anticholinergic Loading Scale; SAA=Serum Anticholinergic Activity. The anticholinergic burden represents the cumulative impact of taking one or more medications that inhibit cholinergic activity. Anticholinergic drugs work by preventing the neurotransmitter acetylcholine from binding to muscarinic receptors, resulting in anticholinergic effects. These effects can be desirable in certain situations, such as with antipsychotics, antidepressants, and analgesics. Huang K-H, Chan Y-F, Shih H-C, Lee C-Y. Relationship between Potentially Inappropriate Anticholinergic Drugs (PIADs) and Adverse Outcomes among Elderly Patients in Taiwan. J Food Drug Anal. 2012;20(4):930–7. Approximately 1 in 11 adults aged 16 to 59 years (9.2%; approximately 3 million adults) and approximately 1 in 5 adults aged 16 to 24 years (18.6%; approximately 1.1 million adults) reported last year drug use in the year ending June 2022; there was no change compared with the year ending March 2020. Wilson NM, Hilmer SN, March LM, Cameron ID, Lord SR, Seibel MJ, et al. Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc. 2011;59(5):875–80.

Asda Great Deal

Free UK shipping. 15 day free returns.
Community Updates
*So you can easily identify outgoing links on our site, we've marked them with an "*" symbol. Links on our site are monetised, but this never affects which deals get posted. Find more info in our FAQs and About Us page.
New Comment